Persistence of apremilast in moderate-to-severe psoriasis: a real-world analysis of 14 147 apremilast- and methotrexate-naive patients in the French National Health Insurance database
Sbidian E, Billionnet C, Weill A, Maura G, Mezzarobba M.
Br J Dermatol. 2020 Mar;182(3):690-697.
doi: 10.1111/bjd.18047. Epub 2019 Jul 22. PMID: 31021438.